Viewing Study NCT00202137



Ignite Creation Date: 2024-05-05 @ 11:59 AM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00202137
Status: COMPLETED
Last Update Posted: 2016-01-14
First Post: 2005-09-13

Brief Title: Home Blood Pressure Monitoring and Blood Pressure Control
Sponsor: Queens University
Organization: Queens University

Study Overview

Official Title: A Randomized Controlled Trial of the Effects of Home Blood Pressure Monitoring on Blood Pressure Control
Status: COMPLETED
Status Verified Date: 2016-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Hypertension is a common problem in Canada with a prevalence of about 15 The goal of hypertension therapy should be to maximize blood pressure control Home blood pressure monitoring HBPM devices are available and many patients are using them The role that self-monitoring of blood pressure can play in optimizing blood pressure control is unclear We hope to clarify the role of home blood pressure monitoring in the treatment of hypertension and explore how it may affect patient and physician behaviours related to blood pressure management This study will compare a group of hypertensive patients who use HBPM with those who do not use these devices The intervention HBPM group will measure their blood pressure at home a minimum of once weekly and will report these measurements to their family doctor at each visit The control group will receive usual care as delivered by their family doctor Outcomes of blood pressure control will be measured over a 12 month period Outcomes will be determined primarily by 24 hour ambulatory blood pressure monitoring and by reviewing data in patients charts located in family physicians office Fifty family physicians from the Kingston area have agreed to participate
Detailed Description: The objective of this study is to measure the effect of home self blood pressure monitoring on control of hypertension in a primary care setting

This research is important for several reasons

i Lack of control of hypertension is common and is associated with morbidity and mortality

ii The costs of managing hypertensions are high not only because of the prevalence of hypertension but also because maintenance of control must exist over many years for most patients

iii Home blood pressure monitoring is increasingly being used by patients

iv Guidelines for home blood pressure monitoring are already being developed and distributed

v While it would seem helpful to increase self-care by patients there is currently conflicting or inadequate evidence that home monitoring is useful

The main hypothesis of the study is that compared to patients who receive usual care patients who use home monitoring will have lower blood pressure levels

Our secondary hypothesis is that HBPM changes physician and patient behaviours in ways that would result in better control of hypertension

The methodology uses cluster randomization Physicians will be randomly allocated to either have their patients use the intervention or to continue with usual care The intervention for the experimental group is the provision of a home blood pressure monitor to patients with a request that they record weekly blood pressure measurements and report them to their family physician at their regular hypertension follow-up visits The physicians will be informed of current guidelines for target levels for home monitored blood pressure The control group will receive usual care

The main outcome measures will be blood pressure level by 24 hour ambulatory monitoring at baseline 6 months and 12 months

The secondary objective of this study is to measure the effect of home monitoring on physicians and patients behaviours related to hypertension control Behaviours that will be measured include the intensity and type of pharmacological treatment compliance with antihypertensive medication and changes in patients lifestyle

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
HSFO Grant T-5345 OTHER_GRANT Ontario Heart and Stroke Foundation None